首页 › 食管癌 › 密歇根州 › Grand Rapids
Grand Rapids MI 食管癌临床试验
14项针对 食管癌的研究正在 Grand Rapids及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
招募中1 期
- START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
招募中欢迎健康志愿者
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Pan-tumor MRD Study
招募中观察性研究
- The Cancer & Hematology Centers (CHC), Grand Rapids
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
招募中1 期
- BAMF Health Inc., Grand Rapids
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
招募中1 期
- BAMF Health Inc., Grand Rapids
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- START Midwest, Grand Rapids
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
招募中观察性研究
- Cancer & Hematology Centers of Western Michigan, Grand Rapids
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
招募中3 期
- Research Site, Grand Rapids
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
招募中1/2 期
- The Cancer and Hematology Centers ( Site 8912), Grand Rapids
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
招募中1/2 期
- The Cancer and Hematology Centers ( Site 6912), Grand Rapids
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
招募中1 期
- START Midwest /ID# 248685, Grand Rapids
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
招募中1/2 期
- START Midwest, Grand Rapids
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
招募中1/2 期
- BAMF Health, Inc., Grand Rapids
其他城市的 食管癌试验
- Houston, TX36 项研究
- Boston, MA23 项研究
- New York City, NY22 项研究
- Nashville, TN19 项研究
- St. Louis, MO17 项研究
- Pittsburgh, PA15 项研究
- Los Angeles, CA15 项研究
- Baldwin Park, CA14 项研究
- Philadelphia, PA13 项研究
- San Antonio, TX12 项研究
- Arlington, VA11 项研究
- Rochester, MN11 项研究
Grand Rapids的其他研究
- 非小细胞肺癌44 项研究
- 结直肠癌40 项研究
- 癌症（所有类型）28 项研究
- 乳腺癌26 项研究
- 卵巢癌24 项研究
- 转移性癌症22 项研究
- 前列腺癌19 项研究
- 子宫内膜癌18 项研究
- 胃癌18 项研究
- 胰腺癌18 项研究
- 黑色素瘤17 项研究
- 头颈鳞状细胞癌15 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。